The impact on pregnant people infected with the severe acute respiratory syndrome coronavirus 2 SARS-CoV-2) may be asymptomatic or symptomatic analysis by Saptadeep Nandi

 The impact on pregnant people infected with the severe acute respiratory syndrome coronavirus 2 SARS-CoV-2) may be asymptomatic or symptomatic. Those who are symptomatic appear to be at increased risk for developing severe squeal of coronavirus disease 2019 (COVID-19) compared with nonpregnant reproductive-aged females.

Need for the study:- 

Diagnosis:-

These physiologic changes make distinguishing pulmonary pathology difficult during pregnancy. This difficulty is heightened by the fact that COVID-19 infection has a wide array of presenting signs of symptoms. COVID-19 symptoms in pregnancy are similar to infections that occur in the general population with respect to presenting symptoms of cough (52%) and shortness of breath (30%). Pregnant women, however, were less likely to report symptoms of headache (41%), fever (34%), chills (38%), and diarrhea (14%) compared to the general population [5]. The other presenting symptoms, although less common, of COVID-19 infection, include loss of appetite, nausea/vomiting, loss of smell, rhinorrhea, sore throat, and abnormal laboratory values of lymphopenia and transaminitis.

TREATMENTS:-

There is current guidance from the Canters for Disease Control and Prevention, the American College of Obstetricians and Gynecologists, and the Society for Maternal-Fetal Medicine

•Pregnant people should be counseled about the increased risk for severe disease from SARS-CoV-2 infection and receive recommendations on ways to protect themselves and their families from infection. •If hospitalization for COVID-19 is indicated for a pregnant patient, care should be provided in a facility that can conduct maternal and fetal monitoring, when appropriate.

COVID-19 Vaccines:-

The CDC recommends COVID-19 vaccination for all people 5 years and older, including people who are pregnant, breastfeeding, trying to get pregnant now, or might become pregnant in the future. Evidence about the safety and effectiveness of COVID-19 vaccination during pregnancy has been growing. These data suggest that the benefits of receiving a COVID-19 vaccine outweigh any known or potential risks of vaccination during pregnancy.

Conclusion:-

We found that SARS-CoV-2 infection in pregnancy was associated with risks of preeclampsia, stillbirth, preterm birth, and NICU admission. In addition, severe SARS-CoV-2 infection was strongly associated with preeclampsia and other adverse maternal and neonatal outcomes. Future studies are needed to collect more robust data to further validate or substantiate these findings, better understand the pathophysiologic pathways that explain these associations, and identify effective strategies to prevent adverse outcomes in pregnant people with COVID-19.